SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience.   The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency <1 second. The chain currently supports 100k orders / second.  The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1.   The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

Hype is trending as traders discuss its potential for further upside, with some eyeing new all-time highs. Community members are actively debating entry points and whether to lock in profits, while others promote staking. Some users are calling it "the house of all finance", and the coin is seeing bullish sentiment as a perp DEX.

Clanker is an autonomous agent for deploying tokens. Currently, users may request clanker to deploy an ERC-20 token on Base by tagging it @clanker on Farcaster.

tokenbot

Clanker Crypto is trending due to its recent acquisition by Farcaster, a decentralized social network, which the community believes will significantly boost the token's utility and value.  Traders are also focused on the project's tokenomics, specifically its aggressive buyback and burn mechanism, and comparing its market cap to other projects in the space. Some users are reporting issues with trading on Coinbase, while others speculate about upcoming exchange listings.

Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.

Hyperion DeFi Inc.

$HYPD is trending as investors discuss its relationship with the $HYPE token and potential benefits from the Kinetiq airdrop. Community members are analyzing recent 13F filings showing institutional investment, while others debate the company's current direction and management's effectiveness. Bullish sentiment revolves around the potential for a short squeeze and significant upside due to the company's treasury strategy.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending as the community discusses its recent price movements and potential for further gains, with some suggesting it's primed for a bounce and others remaining cautious. Bullish sentiment is fueled by the project's focus on virtual asset utility and AI integration, while some traders are pointing to technical indicators and potential resistance levels. Discussions also highlight the broader context of AI in crypto trading and the rise of AI agents.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as the community discusses its recent price surge and potential for further growth, particularly in light of its limited supply and upcoming halving. Some community members are drawing comparisons to Bitcoin, highlighting Zcash's focus on privacy and potential as a store of value. Discussions also revolve around its technical setup and potential price targets.

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

GNTA is trending due to news of improving financials and strong analyst support, sparking community discussion about a potential short squeeze. Some traders are pointing to the stock's high volatility and recent price action, while others are highlighting positive developments and potential for gains. The stock's movement is also being compared to other high-flying tickers.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending due to recent FDA approval of Revuforj, used in leukemia treatment, though market sentiment is mixed, with some concerned about potential side effects, as highlighted by a "black box warning". Community discussions revolve around comparing SNDX to competitor Kura, and whether the approval is fully priced into the stock. Some traders anticipate a buyout and consider the current valuation undervalued, while others believe short sellers are controlling the price.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

Kaspa is trending as the community eagerly anticipates the Crescendo hardfork, set to occur soon, which promises to enhance the blockchain's speed and efficiency by transitioning to Rust. Community members are closely watching for potential listings on major exchanges following the upgrade, speculating this could significantly boost visibility and adoption. Discussion also highlights Kaspa's technology, including its blockDAG architecture, and the potential for smart contracts and real-world asset tokenization.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology ($STX) is trending as investors react to positive analyst ratings, which cite increasing AI-driven demand for data storage solutions and upgrades that could propel the stock higher. Discussions also focus on upcoming earnings and potential breakout moves, with the community watching for confirmation signals. Bullish sentiment is strong, driven by the data storage sector's anticipated growth from AI and cloud investments.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is trending as investors discuss its potential for early cancer detection following promising data and a recent investment from Samsung, with community members highlighting its long-term growth prospects and potential for Medicare coverage. Some are focused on LEAPS option strategies, while others debate its valuation and competitive landscape. The community is also closely watching for FDA approval and broader adoption of its Galleri test.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


greenlegacy

Green Legacy